Renhuang Pharmaceuticals to Present at Rodman & Renshaw Annual China Investment Conference
March 05 2010 - 7:00AM
PR Newswire (US)
HARBIN, China, March 5 /PRNewswire-Asia-FirstCall/ -- Renhuang
Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the
"Company"), a developer, manufacturer and distributor of botanical
products, bio-pharmaceuticals and traditional Chinese medicines
("TCM"), announced today that Mr. Shaoming Li, the Company's
Chairman and CEO, and Ms. Yan Yi Chen, CFO, will present at the
upcoming Rodman & Renshaw Annual China Investment Conference to
be held on March 7-9, 2010. Date: March 9, 2010 Time: 2:50 p.m.
Location: The Regent Hotel - Diamond III 99 Jinbao Street, Beijing,
China During the conference, Company management will be available
for one-on-one meetings with institutional investors. The Rodman
& Renshaw Annual China Investment Conference is a three-day
event which features tracks devoted to Agriculture, Auto, Cleantech
& Energy, Consumer/Retail, Education, Healthcare, Industrial
and Technology industries. For more information about the
conference, please visit http://www.rodm.com/conferences . About
Renhuang Pharmaceuticals, Inc. Renhuang Pharmaceuticals, Inc. is
engaged in the research, development, manufacturing, and
distribution of botanical products, bio-pharmaceutical products,
and traditional Chinese medicines ("TCM"), in the People's Republic
of China. All of the Company's products are produced at its three
GMP-certified production facilities in Ah City, Dongfanghong and
Qingyang. The Company distributes its botanical anti-depression and
nerve-regulation products, biopharmaceutical products, and
botanical antibiotic and OTC TCMs through its extensive
distribution network of over 3,000 distributors and more than 70
sales centers across 24 provinces in China. For more information,
please contact: Company Contact: Renhuang Pharmaceuticals, Inc. Ms.
Portia Tan, IR Contact Tel: +86-451-5392-5461 Email:
ir@renhuang.com CCG Investor Relations: Ms. Lei Huang, Account
Manager Tel: +1-646-833-3417 (New York) Email: lei.huang@ccgir.com
Web: http://www.ccgirasia.com/ Mr. Crocker Coulson, President Tel:
+1-646-213-1915 (New York) Email: crocker.coulson@ccgir.com
DATASOURCE: Renhuang Pharmaceuticals, Inc. CONTACT: Company
Contact: Renhuang Pharmaceuticals, Inc., Ms. Portia Tan,IR Contact,
+86-451-5392-5461, or ir@renhuang.com; Or CCG Investor
Relations:Ms. Lei Huang, Account Manager, +1-646-833-3417 (New
York),lei.huang@ccgir.com; Or Mr. Crocker Coulson, President,
+1-646-213-1915 (NewYork), or crocker.coulson@ccgir.com Web site:
http://www.ccgirasia.com/
Copyright
RHG Ltd (ASX:RHG)
Historical Stock Chart
From May 2024 to Jun 2024
RHG Ltd (ASX:RHG)
Historical Stock Chart
From Jun 2023 to Jun 2024